TAPINAROF - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

What are the generic drug sources for tapinarof and what is the scope of freedom to operate?

Tapinarof is the generic ingredient in one branded drug marketed by Dermavant Sci and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tapinarof has sixty-three patent family members in thirty-six countries.

One supplier is listed for this compound.

Summary for TAPINAROF

International Patents:	63
US Patents:	4
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	51
Clinical Trials:	10
Patent Applications:	193
What excipients (inactive ingredients) are in TAPINAROF?	TAPINAROF excipients list
DailyMed Link:	TAPINAROF at DailyMed

Recent Clinical Trials for TAPINAROF

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dermavant Sciences, Inc.	Phase 4
Dermavant Sciences, Inc.	Phase 2
Dermavant Sciences, Inc.	Phase 3

See all TAPINAROF clinical trials

US Patents and Regulatory Information for TAPINAROF

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dermavant Sci	VTAMA	tapinarof	CREAM;TOPICAL	215272-001	May 23, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dermavant Sci	VTAMA	tapinarof	CREAM;TOPICAL	215272-001	May 23, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y		⤷ Sign Up
Dermavant Sci	VTAMA	tapinarof	CREAM;TOPICAL	215272-001	May 23, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for TAPINAROF

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Costa Rica	20170528	COMPOSICIONES FARMACÉUTICAS TÓPICAS.	⤷ Sign Up
Lithuania	3297605		⤷ Sign Up
European Patent Office	3297605	COMPOSITIONS PHARMACEUTIQUES TOPIQUES (TOPICAL PHARMACEUTICAL COMPOSITIONS)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.